WHO Coronavirus (COVID-19) https://covid19.who.int
•• O’Rourke RW, Lumeng CN. Pathways to severe COVID-19 for people with obesity. Obes Silver Spring Md avr. 2021;29(4):645–53. This review provides a broad overview of the intersection between COVID-19 and the physiology of obesity in order to highlight potential mechanisms by which COVID-19 disease severity is increased by obesity.
Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature août. 2020;584(7821):430–6.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet Lond Engl. 2020;395(10223):497–506.
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan. China JAMA Intern Med. 2020;180(7):934–43.
Article CAS PubMed Google Scholar
Matthay MA, Arabi Y, Arroliga AC, Bernard G, Bersten AD, Brochard LJ, et al. A new global definition of acute respiratory distress syndrome. Am J Respir Crit Care Med. 2024;209(1):37–47.
Kristensen NM, Gribsholt SB, Andersen AL, Richelsen B, Bruun JM. Obesity augments the disease burden in COVID-19: updated data from an umbrella review. Clin Obes. 2022;12(3):e12508.
Article PubMed PubMed Central Google Scholar
Raeisi T, Mozaffari H, Sepehri N, Darand M, Razi B, Garousi N, et al. The negative impact of obesity on the occurrence and prognosis of the 2019 novel coronavirus (COVID-19) disease: a systematic review and meta-analysis. Eat Weight Disord EWD avr. 2022;27(3):893–911.
Huang Y, Lu Y, Huang YM, Wang M, Ling W, Sui Y, et al. Obesity in patients with COVID-19: a systematic review and meta-analysis. Metabolism déc. 2020;113:154378.
Jayawardena R, Jeyakumar DT, Misra A, Hills AP, Ranasinghe P. Obesity: a potential risk factor for infection and mortality in the current COVID-19 epidemic. Diabetes Metab Syndr déc. 2020;14(6):2199–203.
Zhou Y, Yang Q, Chi J, Dong B, Lv W, Shen L, et al. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: a systematic review and meta-analysis. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2020;99:47–56.
Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity juill. 2020;28(7):1195–9.
de Lusignan S, Dorward J, Correa A, Jones N, Akinyemi O, Amirthalingam G, et al. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. Lancet Infect Dis sept. 2020;20(9):1034–42.
Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985.
•• Sudhakar M, Winfred SB, Meiyazhagan G, Venkatachalam DP. Mechanisms contributing to adverse outcomes of COVID-19 in obesity. Mol Cell Biochem. 2022;477(4):1155–93. This review has examined the available literature on the underlying mechanisms contributing to obesity being a risk for adverse outcome in COVID-19.
Hendren NS, de Lemos JA, Ayers C, Das SR, Rao A, Carter S, et al. Association of body mass index and age with morbidity and mortality in patients hospitalized with COVID-19: results from the American Heart Association COVID-19 Cardiovascular Disease Registry. Circulation. 2021;143(2):135–44.
Article CAS PubMed Google Scholar
Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, et al. Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev Off J Int Assoc Study Obes. 2020;21(11):e13128.
Pedersen SF, Ho YC. SARS-CoV-2: a storm is raging. J Clin Invest. 2020;130(5):2202–5.
Article CAS PubMed PubMed Central Google Scholar
Behrens EM, Koretzky GA. Review: cytokine storm syndrome: looking toward the precision medicine era. Arthritis Rheumatol Hoboken NJ juin. 2017;69(6):1135–43.
Kooistra EJ, de Nooijer AH, Claassen WJ, Grondman I, Janssen NAF, Netea MG, et al. A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients. Int J Obes 2021;45(3):687–94.
Maurya R, Sebastian P, Namdeo M, Devender M, Gertler A. COVID-19 severity in obesity: leptin and inflammatory cytokine interplay in the link between high morbidity and mortality. Front Immunol. 2021;12:649359.
Article CAS PubMed PubMed Central Google Scholar
Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–4.
Article CAS PubMed PubMed Central Google Scholar
Al-Benna S. Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients. Obes Med sept. 2020;19:100283.
Beloncle F, Studer A, Seegers V, Richard JC, Desprez C, Fage N, et al. Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome. Crit Care Lond Engl. 2021;25(1):248.
Grieco DL, Bongiovanni F, Chen L, Menga LS, Cutuli SL, Pintaudi G, et al. Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies. Crit Care Lond Engl. 2020;24(1):529.
• Reddy MP, Subramaniam A, Chua C, Ling RR, Anstey C, Ramanathan K, et al. Respiratory system mechanics, gas exchange, and outcomes in mechanically ventilated patients with COVID-19-related acute respiratory distress syndrome: a systematic review and meta-analysis. Lancet Respir Med déc. 2022;10(12):1178–88. This article showed the absence of evidence of distinct phenotypes in patients with COVID-19-related ARDS.
Fan E, Beitler JR, Brochard L, Calfee CS, Ferguson ND, Slutsky AS, et al. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Respir Med août. 2020;8(8):816–21.
Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obes Silver Spring Md juill. 2020;28(7):1195–9.
Zdravković V, Stevanović Đ, Ćićarić N, Zdravković N, Čekerevac I, Poskurica M, et al. Anthropometric measurements and admission parameters as predictors of acute respiratory distress syndrome in hospitalized COVID-19 patients. Biomedicines. 2023;11(4):1199.
Article PubMed PubMed Central Google Scholar
• Li Y, Li C, Chang W, Liu L. High-flow nasal cannula reduces intubation rate in patients with COVID-19 with acute respiratory failure: a meta-analysis and systematic review. BMJ Open. 2023;13(3):e067879. This study showed that HFNC may reduce intubation rate and 28-day ICU mortality in patients with acute respiratory failure.
•• Thille AW, Coudroy R, Nay MA, Gacouin A, Decavèle M, Sonneville R, et al. Beneficial effects of noninvasive ventilation after extubation in obese or overweight patients: a post hoc analysis of a randomized clinical trial. Am J Respir Crit Care Med. 2022;205(4):440–9 This article showed the benefit of NIV in obese patients as a new strategy after extubation in obese patients.
Nahum J, Morichau-Beauchant T, Daviaud F, Echegut P, Fichet J, Maillet JM, et al. Venous thrombosis among critically ill patients with coronavirus disease 2019 (COVID-19). JAMA Netw Open. 2020;3(5):e2010478.
Article PubMed PubMed Central Google Scholar
Porfidia A, Valeriani E, Pola R, Porreca E, Rutjes AWS, Di Nisio M. Venous thromboembolism in patients with COVID-19: systematic review and meta-analysis. Thromb Res déc. 2020;196:67–74.
Silver SA, Beaubien-Souligny W, Shah PS, Harel S, Blum D, Kishibe T, et al. The prevalence of acute kidney injury in patients hospitalized with COVID-19 infection: a systematic review and meta-analysis. Kidney Med févr. 2021;3(1):83–98.e1.
Moledina DG, Simonov M, Yamamoto Y, Alausa J, Arora T, Biswas A, et al. The association of COVID-19 with acute kidney injury independent of severity of illness: a multicenter cohort study. Am J Kidney Dis Off J Natl Kidney Found. 2021;77(4):490–499.e1.
Huang HK, Bukhari K, Peng CCH, Hung DP, Shih MC, Chang RHE, et al. The J-shaped relationship between body mass index and mortality in patients with COVID-19: a dose-response meta-analysis. Diabetes Obes Metab juill. 2021;23(7):1701–9.
Yang J, Ma Z, Lei Y. A meta-analysis of the association between obesity and COVID-19. Epidemiol Infect. 2020;149.
Zhao X, Gang X, He G, Li Z, Lv Y, Han Q, et al. Obesity increases the severity and mortality of influenza and COVID-19: a systematic review and meta-analysis. Front Endocrinol. 2020;11:595109.
Tadayon Najafabadi B, Rayner DG, Shokraee K, Panahi P, Rastgou P, et al. Obesity as an independent risk factor for COVID-19 severity and mortality. Cochrane Database Syst Rev. 2023;5(5):CD015201.
Ni YN, Luo J, Yu H, Wang YW, Hu YH, Liu D, et al. Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis Crit Care. 2017;21:36.
Zhi G, Xin W, Ying W, Guohong X, Shuying L. Obesity paradox in acute respiratory distress syndrome: a systematic review and meta-analysis. PLoS ONE. 2016;11(9):e0163677.
Article PubMed PubMed Central Google Scholar
Schetz M, De Jong A, Deane AM, Druml W, Hemelaar P, Pelosi P, et al. Obesity in the critically ill: a narrative review. Intensive Care Med. 2019;45(6):757–69.
•• Kooistra EJ, Brinkman S, van der Voort PHJ, de Keizer NF, Dongelmans DA, Kox M, et al. Body mass index and mortality in coronavirus disease 2019 and other diseases: a cohort study in 35,506 ICU patients. Crit Care Med janv. 2022;50(1):e1-10 This study showed the absence of an obesity paradox in ICU patients with COVID-19 in contrast to nonsevere acute respiratory syndrome coronavirus 2 viral and bacterial respiratory infections.
Comments (0)